Immunogenicity of Immunotoxins Containing Pseudomonas Exotoxin A: Causes, Consequences, and Mitigation
出版年份 2020 全文链接
标题
Immunogenicity of Immunotoxins Containing Pseudomonas Exotoxin A: Causes, Consequences, and Mitigation
作者
关键词
-
出版物
Frontiers in Immunology
Volume 11, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2020-06-27
DOI
10.3389/fimmu.2020.01261
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Moxetumomab pasudotox: A first-in-class treatment for hairy cell leukemia
- (2019) Karen M Fancher et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Deimmunizing substitutions in Pseudomonas exotoxin domain III perturb antigen processing without eliminating T-cell epitopes
- (2019) Daniel L. Moss et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Depletion of PD-1-positive cells ameliorates autoimmune disease
- (2019) Peng Zhao et al. Nature Biomedical Engineering
- The engineered anti‐GPC3 immunotoxin, HN3‐ABD‐T20, produces regression in mouse liver cancer xenografts via prolonged serum retention
- (2019) Bryan D. Fleming et al. HEPATOLOGY
- A novel approach to assess domain specificity of anti-drug antibodies to moxetumomab pasudotox, an immunotoxin with two functional domains
- (2019) Inna Vainshtein et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Contextualizing the Use of Moxetumomab Pasudotox in the Treatment of Relapsed or Refractory Hairy Cell Leukemia
- (2019) Robert J. Kreitman et al. ONCOLOGIST
- Targeted Diphtheria Toxin-Based Therapy: A Review Article
- (2019) Fatemeh Shafiee et al. Frontiers in Microbiology
- Strategies to Reduce the Immunogenicity of Recombinant Immunotoxins
- (2018) Ronit Mazor et al. AMERICAN JOURNAL OF PATHOLOGY
- Low-Dose Methotrexate Prevents Primary and Secondary Humoral Immune Responses and Induces Immune Tolerance to a Recombinant Immunotoxin
- (2018) Emily M. King et al. JOURNAL OF IMMUNOLOGY
- Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia
- (2018) Robert J. Kreitman et al. LEUKEMIA
- Improving theIn VivoEfficacy of an Anti-Tac (CD25) Immunotoxin byPseudomonasExotoxin A Domain II Engineering
- (2018) Gilad Kaplan et al. MOLECULAR CANCER THERAPEUTICS
- Tolerogenic nanoparticles restore the antitumor activity of recombinant immunotoxins by mitigating immunogenicity
- (2018) Ronit Mazor et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Phase I/II Trial of a Combination of Anti-CD3/CD7 Immunotoxins for Steroid-Refractory Acute Graft-versus-Host Disease
- (2018) Christoph Groth et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Moxetumomab Pasudotox: First Global Approval
- (2018) Sohita Dhillon DRUGS
- Targeting the latent cytomegalovirus reservoir with an antiviral fusion toxin protein
- (2017) B. A. Krishna et al. Nature Communications
- Role of HLA-DP in the Presentation of Epitopes from the Truncated Bacterial PE38 Immunotoxin
- (2016) Ronit Mazor et al. AAPS Journal
- Hypersensitivity and immunologic reactions to biologics: opportunities for the allergist
- (2016) David A. Khan ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Immunogenicity of therapeutic recombinant immunotoxins
- (2016) Ronit Mazor et al. IMMUNOLOGICAL REVIEWS
- Mesothelin Immunotherapy for Cancer: Ready for Prime Time?
- (2016) Raffit Hassan et al. JOURNAL OF CLINICAL ONCOLOGY
- An immunoinhibition approach to overcome the impact of pre-existing antibodies on cut point establishment for immunogenicity assessment of moxetumomab pasudotox
- (2016) Amy K. Schneider et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Characterization of a re-engineered, mesothelin-targeted Pseudomonas exotoxin fusion protein for lung cancer therapy
- (2016) Frieder Bauss et al. Molecular Oncology
- Dual B- and T-cell de-immunization of recombinant immunotoxin targeting mesothelin with high cytotoxic activity
- (2016) Ronit Mazor et al. Oncotarget
- Phase I trial of EpCAM-targeting immunotoxin MOC31PE, alone and in combination with cyclosporin
- (2015) Y Andersson et al. BRITISH JOURNAL OF CANCER
- Elimination of murine and human T-cell epitopes in recombinant immunotoxin eliminates neutralizing and anti-drug antibodies in vivo
- (2015) Ronit Mazor et al. Cellular & Molecular Immunology
- Complete Remissions of Adult T-cell Leukemia with Anti-CD25 Recombinant Immunotoxin LMB-2 and Chemotherapy to Block Immunogenicity
- (2015) R. J. Kreitman et al. CLINICAL CANCER RESEARCH
- Enzyme Replacement Therapies and Immunogenicity in Lysosomal Storage Diseases: Is There a Pattern?
- (2015) Paul Harmatz CLINICAL THERAPEUTICS
- Poor correlation between T-cell activation assays and HLA-DR binding prediction algorithms in an immunogenic fragment of Pseudomonas exotoxin A
- (2015) Ronit Mazor et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Bortezomib Reduces Pre-Existing Antibodies to Recombinant Immunotoxins in Mice
- (2015) Michael L. Manning et al. JOURNAL OF IMMUNOLOGY
- Recombinant Immunotoxin with T-cell Epitope Mutations That Greatly Reduce Immunogenicity for Treatment of Mesothelin-Expressing Tumors
- (2015) R. Mazor et al. MOLECULAR CANCER THERAPEUTICS
- Mutagenic Deimmunization of Diphtheria Toxin for Use in Biologic Drug Development
- (2015) Joerg U. Schmohl et al. Toxins
- Pseudomonas Exotoxin A: optimized by evolution for effective killing
- (2015) Marta Michalska et al. Frontiers in Microbiology
- Identification of Immunodominant CD4-Restricted Epitopes Co-Located with Antibody Binding Sites in Individuals Vaccinated with ALVAC-HIV and AIDSVAX B/E
- (2015) Silvia Ratto-Kim et al. PLoS One
- Immunotoxins for leukemia
- (2014) A. S. Wayne et al. BLOOD
- Tofacitinib Suppresses Antibody Responses to Protein Therapeutics in Murine Hosts
- (2014) M. Onda et al. JOURNAL OF IMMUNOLOGY
- In Vitro and In Vivo Activity of the Low-Immunogenic Antimesothelin Immunotoxin RG7787 in Pancreatic Cancer
- (2014) K. Hollevoet et al. MOLECULAR CANCER THERAPEUTICS
- Efficacy of RG7787, a Next-Generation Mesothelin-Targeted Immunotoxin, against Triple-Negative Breast and Gastric Cancers
- (2014) C. Alewine et al. MOLECULAR CANCER THERAPEUTICS
- Removing T-cell epitopes with computational protein design
- (2014) C. King et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Recombinant immunotoxin for cancer treatment with low immunogenicity by identification and silencing of human T-cell epitopes
- (2014) R. Mazor et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Role of Mesothelin in Tumor Progression and Targeted Therapy
- (2013) Zhewei Tang et al. Anti-Cancer Agents in Medicinal Chemistry
- Construction of an Immunotoxin, D2C7-(scdsFv)-PE38KDEL, Targeting EGFRwt and EGFRvIII for Brain Tumor Therapy
- (2013) V. Chandramohan et al. CLINICAL CANCER RESEARCH
- Shaping T Cell – B Cell Collaboration in the Response to Human Immunodeficiency Virus Type 1 Envelope Glycoprotein gp120 by Peptide Priming
- (2013) N. Kalaya Steede et al. PLoS One
- The role of DMARDs in reducing the immunogenicity of TNF inhibitors in chronic inflammatory diseases
- (2013) M. Jani et al. RHEUMATOLOGY
- Major Cancer Regressions in Mesothelioma After Treatment with an Anti-Mesothelin Immunotoxin and Immune Suppression
- (2013) R. Hassan et al. Science Translational Medicine
- Immunotoxins: The Role of the Toxin
- (2013) Antonella Antignani et al. Toxins
- T Cells Expressing Chimeric Antigen Receptors Can Cause Anaphylaxis in Humans
- (2013) M. V. Maus et al. Cancer Immunology Research
- Successful immune tolerance induction to enzyme replacement therapy in CRIM-negative infantile Pompe disease
- (2012) Yoav H. Messinger et al. GENETICS IN MEDICINE
- Phase I Trial of Anti-CD22 Recombinant Immunotoxin Moxetumomab Pasudotox (CAT-8015 or HA22) in Patients With Hairy Cell Leukemia
- (2012) Robert J. Kreitman et al. JOURNAL OF CLINICAL ONCOLOGY
- Identification and elimination of an immunodominant T-cell epitope in recombinant immunotoxins based on Pseudomonas exotoxin A
- (2012) R. Mazor et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Recombinant immunotoxin engineered for low immunogenicity and antigenicity by identifying and silencing human B-cell epitopes
- (2012) W. Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A guide to taming a toxin - recombinant immunotoxins constructed from Pseudomonas exotoxin A for the treatment of cancer
- (2011) John E. Weldon et al. FEBS Journal
- Recombinant immunotoxin against B-cell malignancies with no immunogenicity in mice by removal of B-cell epitopes
- (2011) M. Onda et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Peptide binding predictions for HLA DR, DP and DQ molecules
- (2010) Peng Wang et al. BMC BIOINFORMATICS
- Molecular Determinants of T Cell Epitope Recognition to the Common Timothy Grass Allergen
- (2010) C. Oseroff et al. JOURNAL OF IMMUNOLOGY
- A Recombinant Immunotoxin Targeting CD22 With Low Immunogenicity, Low Nonspecific Toxicity, and High Antitumor Activity in Mice
- (2010) Johanna K. Hansen et al. JOURNAL OF IMMUNOTHERAPY
- The immunogenicity of humanized and fully human antibodies
- (2010) Fiona A. Harding et al. mAbs
- Immunotoxin Complementation of HAART to Deplete Persisting HIV-Infected Cell Reservoirs
- (2010) Edward A. Berger et al. PLoS Pathogens
- Removal of B cell epitopes as a practical approach for reducing the immunogenicity of foreign protein-based therapeutics☆
- (2009) Satoshi Nagata et al. ADVANCED DRUG DELIVERY REVIEWS
- Phase I Trial of Continuous Infusion Anti-Mesothelin Recombinant Immunotoxin SS1P
- (2009) R. J. Kreitman et al. CLINICAL CANCER RESEARCH
- A protease-resistant immunotoxin against CD22 with greatly increased activity against CLL and diminished animal toxicity
- (2008) J. E. Weldon et al. BLOOD
- Pseudomonas exotoxin A: From virulence factor to anti-cancer agent
- (2008) Philipp Wolf et al. INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY
- Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose
- (2008) Christine H. Chung et al. NEW ENGLAND JOURNAL OF MEDICINE
- An immunotoxin with greatly reduced immunogenicity by identification and removal of B cell epitopes
- (2008) M. Onda et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now